Literature DB >> 32242646

Consensus statement on the use of clozapine during the COVID-19 pandemic

Dan Siskind1, William G. Honer, Scott Clark, Christoph U. Correll, Alkomiet Hasan, Oliver Howes, John M. Kane, Deanna L. Kelly, Robert Laitman, Jimmy Lee, James H. MacCabe, Nick Myles, Jimmi Nielsen, Peter F. Schulte, David Taylor, Helene Verdoux, Amanda Wheeler, Oliver Freudenreich.   

Abstract

Entities:  

Year:  2020        PMID： 32242646

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN： 1180-4882            Impact factor:   6.186


× No keyword cloud information.
  16 in total

1.  Clozapine and COVID-19: The authors respond.

Authors:  Dan Siskind; William G Honer; Scott Clark; Christoph U Correll; Alkomiet Hasan; Oliver Howes; John M Kane; Deanna L Kelly; Robert Laitman; Jimmy Lee; James H MacCabe; Nick Myles; Jimmi Nielsen; Peter F Schulte; David Taylor; Helene Verdoux; Amanda Wheeler; Oliver Freudenreich
Journal:  J Psychiatry Neurosci       Date:  2020-07-01       Impact factor: 6.186

Review 2.  Schizophrenia during the COVID-19 pandemic.

Authors:  Stefano Barlati; Gabriele Nibbio; Antonio Vita
Journal:  Curr Opin Psychiatry       Date:  2021-05-01       Impact factor: 4.787

3.  Facing the Change Together: Reflections of Coping and Resilience From American Geriatric Psychiatrists During COVID-19.

Authors:  Carmen Black Parker; Malcolm P Forbes; Ipsit V Vahia; Brent P Forester; Dilip V Jeste; Charles F Reynolds
Journal:  Am J Geriatr Psychiatry       Date:  2020-07-23       Impact factor: 4.105

Review 4.  Coronavirus and Its Implications for Psychiatry: A Rapid Review of the Early Literature.

Authors:  Maximilliam A Cabrera; Lakshmipriya Karamsetty; Scott A Simpson
Journal:  Psychosomatics       Date:  2020-05-27       Impact factor: 2.386

5.  SARS-CoV-2 Risk Management in Clinical Psychiatry: A Few Considerations on How to Deal With an Unrivaled Threat.

Authors:  Peter M Kreuzer; Thomas C Baghai; Rainer Rupprecht; Markus Wittmann; Dagmar Steffling; Michael Ziereis; Marc Zowe; Helmut Hausner; Berthold Langguth
Journal:  Front Psychiatry       Date:  2020-06-11       Impact factor: 4.157

Review 6.  Psychopharmacology of COVID-19.

Authors:  Melanie Bilbul; Patricia Paparone; Anna M Kim; Shruti Mutalik; Carrie L Ernst
Journal:  Psychosomatics       Date:  2020-05-18       Impact factor: 2.386

7.  Community Mental Health Care Delivery During the COVID-19 Pandemic: Practical Strategies for Improving Care for People with Serious Mental Illness.

Authors:  Sarah L Kopelovich; Maria Monroe-DeVita; Benjamin E Buck; Carolyn Brenner; Lorna Moser; L Fredrik Jarskog; Steve Harker; Lydia A Chwastiak
Journal:  Community Ment Health J       Date:  2020-06-19

8.  Clozapine treated patients and COVID-19: Ensuring continued care through collaboration.

Authors:  Jonathan G Leung; Terri S Wittenberger; Kathryn M Schak
Journal:  Schizophr Res       Date:  2020-05-14       Impact factor: 4.939

Review 9.  [Psychopharmacotherapy during the COVID-19 pandemic].

Authors:  J Seifert; J Heck; G Eckermann; M Singer; S Bleich; R Grohmann; S Toto
Journal:  Nervenarzt       Date:  2020-07       Impact factor: 1.214

10.  Management of clozapine treatment during the COVID-19 pandemic.

Authors:  Siobhan Gee; Fiona Gaughran; James MacCabe; Sukhi Shergill; Eromona Whiskey; David Taylor
Journal:  Ther Adv Psychopharmacol       Date:  2020-05-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.